DE1568372C3 - 7 alpha-Äthylthio-17 beta-hydroxy-17 alpha-methyl-5-alpha androstane eckige Klammer auf 3,2-C eckige Klammer zu pyrazol und Verfahren zu seiner Herstellung - Google Patents

7 alpha-Äthylthio-17 beta-hydroxy-17 alpha-methyl-5-alpha androstane eckige Klammer auf 3,2-C eckige Klammer zu pyrazol und Verfahren zu seiner Herstellung

Info

Publication number
DE1568372C3
DE1568372C3 DE1568372A DE1568372A DE1568372C3 DE 1568372 C3 DE1568372 C3 DE 1568372C3 DE 1568372 A DE1568372 A DE 1568372A DE 1568372 A DE1568372 A DE 1568372A DE 1568372 C3 DE1568372 C3 DE 1568372C3
Authority
DE
Germany
Prior art keywords
hydroxy
compound
pyrazole
methyl
anabolic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE1568372A
Other languages
German (de)
English (en)
Other versions
DE1568372A1 (de
DE1568372B2 (de
Inventor
Hidehiko Kaneko
Keiji Amagasaki Nakamura
Yuzuru Yamato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Publication of DE1568372A1 publication Critical patent/DE1568372A1/de
Publication of DE1568372B2 publication Critical patent/DE1568372B2/de
Application granted granted Critical
Publication of DE1568372C3 publication Critical patent/DE1568372C3/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE1568372A 1965-03-03 1966-03-01 7 alpha-Äthylthio-17 beta-hydroxy-17 alpha-methyl-5-alpha androstane eckige Klammer auf 3,2-C eckige Klammer zu pyrazol und Verfahren zu seiner Herstellung Expired DE1568372C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1229465 1965-03-03

Publications (3)

Publication Number Publication Date
DE1568372A1 DE1568372A1 (de) 1970-03-19
DE1568372B2 DE1568372B2 (de) 1974-09-12
DE1568372C3 true DE1568372C3 (de) 1975-05-28

Family

ID=11801296

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1568372A Expired DE1568372C3 (de) 1965-03-03 1966-03-01 7 alpha-Äthylthio-17 beta-hydroxy-17 alpha-methyl-5-alpha androstane eckige Klammer auf 3,2-C eckige Klammer zu pyrazol und Verfahren zu seiner Herstellung

Country Status (3)

Country Link
DE (1) DE1568372C3 (enrdf_load_stackoverflow)
FR (1) FR7296M (enrdf_load_stackoverflow)
GB (1) GB1070044A (enrdf_load_stackoverflow)

Also Published As

Publication number Publication date
GB1070044A (en) 1967-05-24
FR7296M (enrdf_load_stackoverflow) 1969-09-29
DE1568372A1 (de) 1970-03-19
DE1568372B2 (de) 1974-09-12

Similar Documents

Publication Publication Date Title
DE3688001T2 (de) Fruchtbarkeitsmittel enthaltend extrakte von coix lacryma-jobi oder ferulylstanolderivate und/oder fettsaeure-phytosterolester.
CH643565A5 (de) Derivate von androstan-17-aethern.
DE2818164A1 (de) 1,3-dibenzoesaeureester des 17alpha- ethinyl-7 alpha -methyl-1,3,5(10)-oestratrien- 1,3,17 beta -triols, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE2260138A1 (de) Stoffwechselwirksame bisphenolalkanderivate
DE60224982T2 (de) Androgenische 7-substituierte 11-halogenierte steroide
DE1568372C3 (de) 7 alpha-Äthylthio-17 beta-hydroxy-17 alpha-methyl-5-alpha androstane eckige Klammer auf 3,2-C eckige Klammer zu pyrazol und Verfahren zu seiner Herstellung
DE2610497C2 (de) In 16-Stellung disubstituierte 3- Ketosteroide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2723876A1 (de) 17 beta-ester von testosteron und 5 alpha-dihydrotestosteron
DE1298993B (de) 3-Oxo-8ª‡-17ª‰-hydroxy-17ª‡-aethinyl-oestr-5(10)-en in seiner racemischen und linksdrehenden Form und Verfahren zur Herstellung dieser Verbindungen
DE2501091A1 (de) 17-alpha-aethinyl-(5-alpha)-2-androsten-17-beta-ol und sein 17-beta-acetat, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DE3336292A1 (de) Neue dichlorderivate der 16(alpha)-methylpregnanreihe, deren herstellung, deren verwendung als arzneimittel und die sie enthaltenden zusammensetzungen
DE2425822A1 (de) 17 beta-hydroxy-16,16-dimethyloestr-4en-3-on und verfahren zur herstellung desselben
EP0031591A1 (de) 2,2-Dimethyl-3-oxoandrosta-4,6-dien-17S-spiro-5'-(2'-oxo-3'-methyloxazolidin), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
US3499965A (en) 7alpha - lower alkylthio - 17beta - hydroxy - 17alpha- methyl - 5alpha - androstano(3,2 - c)pyrazole and novel intermediates useful in the preparation thereof
DE60026608T2 (de) 3-methylen steroid derivate zur behandlung von autoimmunerkrankungen
DE1493032C (de) Verfahren zur Herstellung von 2 alpha. 3 alpha-Epithiosteroiden
DE2553997A1 (de) Ester von 19-nor-testosteron
DE2110428C3 (de) 1,2-Diphenyläthanderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1468919C (de) 3,11 Dioxo steroid 4,9 diene und ein Verfahren zu ihrer Herstellung
DE1768700C (de) Ungesättigte 2,2-DimethyI-steroide der Östran- bzw. Gonanreihe und Verfahren zu ihrer Herstellung
DE1668716C (de) 4-Östren-3-on-17 beta-ol-17-phenoxyacetate und Verfahren zu ihrer Herstellung
DE1618752C3 (de) Oral verabreichbares Mittel mit konzeptionsverhütender Wirksamkeit
DE1493164C3 (de) lbeta-Halomethylandrostane und Verfahren zu ihrer Herstellung
DE2607575A1 (de) Triazolocycloalkylhydrothiadiazin- derivate, verfahren zu deren herstellung, sowie dieselben enthaltende pharmazeutische praeparate
Fasolino A Study on the Steroid Fraction of the Crustacean, Cancer Magister

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)